Table 7.

Breakdown of costs (per average patient)

Breakdown of costs	Empagliflozin + SoC	Sitagliptin + SoC	Saxagliptin + SoC
Total	50,801	47,627	48,071
Treatment	13,017	10,883	10,877
Management	581	537	521
Cardiovascular disease	24,097	22,172	21,830
Renal disease	10,517	11,629	12,432
Ulcer/amputation/neuropathy	430	394	378
Eye disease	1025	995	936
Non-severe hypoglycaemia event	479	425	410
Severe hypoglycaemia event (req. non med. assistance)	504	450	517
Severe hypoglycaemia event (req. med. assistance)	151	142	171

SoC standard of care